Retension Pharmaceuticals, Inc. Common Stock

Retension Pharmaceuticals, Inc. Common Stock(RTSN)の株価予測

$10.720

-0.809 (-7.55%)終値時点

価格予想

1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

アプリで開くと、より長期の予想を確認できます。

Loading chart…

Retension Pharmaceuticals, Inc. Common Stock 株は買うべき?

Retension Pharmaceuticals may not be a good buy right now due to its current price of $11.44, which is significantly below the analyst's target of $55, but the recent 5-day decline of 19.66% raises concerns about short-term performance. The company has reported negative net income in the last four quarters, with a loss of $4,170,589 in Q2 2026, indicating ongoing financial struggles.

RTSN の株価は Thursday に $10.72 で引け、その前に下落 -7.55%

Retension Pharmaceuticals, Inc. Common Stock (RTSN) last closed at $10.7200003, losing -7.55%. These facts feed the 1-day and 1-week RTSN price prediction above.

予想の要因

Retension Pharmaceuticals, Inc. Common Stock(RTSN)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。

Seasonality

Negative

Bearish

RTSN の季節性分析

Loading chart…

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める